节点文献

肝脾动脉联合栓塞治疗原发性肝癌合并脾功能亢进的临床观察

Clinical Observation of TACE Combined with PSE Treating Hepatocellular Carcinoma with Hypersplenism

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 郭秀英郭志刘方张俊义邢纪中

【Author】 Guo Xiuying Guo Zhi Liu Fang et alDepartment of Interventional Therapy, Tianjin Cancer Hospital of Tianjin Medical University, Tianjin

【机构】 天津医科大学附属肿瘤医院介入科天津医科大学附属肿瘤医院介入科 天津市300060天津市300060天津市300060

【摘要】 目的:观察肝脾动脉联合栓塞治疗原发性肝癌合并脾功能亢进的疗效与安全性。方法:采用肝动脉化疗栓塞术(TACE)联合部分脾栓塞(PSE)治疗并发肝硬化、门脉高压和脾功能亢进的原发性肝癌患者30例,观察术后瘤体缩小程度和脾功能亢进缓解情况。结果:肝癌瘤体缩小有效率达73.33%;28例脾功能亢进缓解,有效率达93.33%。未发生脾脓肿等严重并发症。结论:TACE联合PSE是治疗原发性肝癌并发肝硬化、门脉高压和脾功能亢进安全、有效的方法。

【Abstract】 Objective: To observe the effectiveness and safety of transcatheter arterial chemoembolization (TACE) combined with partial splenic embolization (PSE) treating primary hepatocelluar carcinomar (HCC) with hypersplenism. Methods: Thirty patients with liver cirrhosis,portal hypertension and hypersplenism were treated by TACE and PSE to observe the degree for reduction of tumor volume and remission of hypersplenism. Results: Tumor reduction rate of HCC patients was 73.33%. The emission rate in 28 hypersplenism patients was 93.33% and there was no severe complication such as hepatic abscess. Conclusion: TACE combined with PSE is a safe and effective method to treat HCC with liver cirrhosis, portal hypertension and hypersplenism.

  • 【文献出处】 中国肿瘤临床 ,Chinese Journal of Clinical Oncology , 编辑部邮箱 ,2004年17期
  • 【分类号】R735.7
  • 【被引频次】1
  • 【下载频次】83
节点文献中: 

本文链接的文献网络图示:

本文的引文网络